Summary
OpenAI’s entry into consumer health is not speculative innovation but a response to behaviour already happening at scale. For the NHS, it exposes a long-ignored gap in law, interoperability and patient agency that policy can no longer sidestep, writes Jonathan Probets in this HSJ article.
Recommended Comments
Create an account or sign in to comment